Douglas B. Muchmore

Douglas B. Muchmore

Keine laufenden Positionen mehr

Health Technology
Consumer Services
Health Services

Ursprung des Netzwerks ersten Grades von Douglas B. Muchmore

EinheitArt der EinheitIndustrie
Public Company Biotechnology 31
Scripps Clinic Foundation
2
Foundation/Endowment Hospital/Nursing Management 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Douglas B. Muchmore

UnternehmenSektorVerknüpfte PersonenHauptposition
AMGEN INC. Pharmaceuticals: Major

Jonathan Leff

Helen Torley

Joy Zhu

Kurt Gustafson

James Daly

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

Biotechnology

John Stuart Patton

John G. Curd

H. Shepard

Kristina Cutter

Chief Tech/Sci/R&D Officer

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

Corporate Officer/Principal

IGNYTA INC Biotechnology

Jonathan Lim

Igor Bilinsky

Zachary Hornby

William Mccarthy

Chief Executive Officer

Corporate Officer/Principal

Director of Finance/CFO

Corporate Officer/Principal

University of California, Los Angeles College/University

William F. Daly

Kurt Gustafson

Athena Countouriotis

Graduate Degree

Masters Business Admin

Undergraduate Degree

University of California San Diego College/University

Robert Engler

Matthew Posard

John Stuart Patton

Corporate Officer/Principal

Undergraduate Degree

Doctorate Degree

Stanford University College/University

Jean Liu

Jonathan Lim

Zachary Hornby

Graduate Degree

Corporate Officer/Principal

Graduate Degree

NEUROCRINE BIOSCIENCES, INC. Pharmaceuticals: Major

Robert J. Little

Zachary Hornby

William Mccarthy

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

ALLERGAN, INC. Pharmaceuticals: Major

Harry Leonhardt

William F. Daly

Corporate Officer/Principal

Corporate Officer/Principal

ERASCA, INC. Pharmaceuticals: Major

Jean Liu

Jonathan Lim

Director/Board Member

Chief Executive Officer

Medical Specialties

Thomas A. Waltz

Harry Leonhardt

Director/Board Member

General Counsel

College/University

Jonathan Lim

John G. Curd

Graduate Degree

Doctorate Degree

Investment Managers

Jonathan Lim

Zachary Hornby

Founder

Private Equity Investor

Pharmaceuticals: Major

Jonathan Lim

Zachary Hornby

Chief Executive Officer

Chief Operating Officer

INTERMUNE INC Biotechnology

Jonathan Leff

Jim Shaffer

Chief Tech/Sci/R&D Officer

Sales & Marketing

IOVANCE BIOTHERAPEUTICS, INC. Biotechnology

Igor Bilinsky

Athena Countouriotis

Chief Operating Officer

Director/Board Member

DURECT CORPORATION Pharmaceuticals: Major

Jean Liu

Schond Greenway

Consultant / Advisor

Public Communications Contact

CARDIFF ONCOLOGY, INC. Medical Specialties

Matthew Posard

Athena Countouriotis

Corporate Officer/Principal

Director/Board Member

Miscellaneous Commercial Services

Gregory Ian Frost

Harry Leonhardt

Director/Board Member

Director/Board Member

ANTARES PHARMA, INC. Pharmaceuticals: Major

Helen Torley

Nicole LaBrosse

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Joy Zhu

William F. Daly

Corporate Officer/Principal

Corporate Officer/Principal

Medical/Nursing Services

Robert Engler

Gregory Ian Frost

Corporate Officer/Principal

Corporate Officer/Principal

Miscellaneous Commercial Services

Robert Engler

Gregory Ian Frost

Corporate Officer/Principal

Corporate Officer/Principal

BRISTOL-MYERS SQUIBB COMPANY Pharmaceuticals: Major

Helen Torley

Athena Countouriotis

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Major

Jim Shaffer

James Daly

Sales & Marketing

Corporate Officer/Principal

BOUNDLESS BIO, INC. Biotechnology

Jonathan Lim

Zachary Hornby

Founder

Chief Executive Officer

XENCOR, INC. Biotechnology

Kurt Gustafson

Director/Board Member

SPECTRUM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Kurt Gustafson

Director of Finance/CFO

Amgen International AG

Kurt Gustafson

Director of Finance/CFO

CHROMADEX CORPORATION Pharmaceuticals: Other

Kurt Gustafson

Director/Board Member

Medical Distributors

Kurt Gustafson

Director of Finance/CFO

Biotechnology

Kurt Gustafson

Director of Finance/CFO

OMNIAB, INC. Miscellaneous Commercial Services

Kurt Gustafson

Director of Finance/CFO

COHERUS BIOSCIENCES, INC. Pharmaceuticals: Major

James Daly

Director/Board Member

Biotechnology

Jean Bizzari

Director/Board Member

PIERIS PHARMACEUTICALS, INC. Biotechnology

Jean Bizzari

Director/Board Member

University of Nice Sophia Antipolis College/University

Jean Bizzari

Doctorate Degree

CELATOR PHARMACEUTICALS INC Pharmaceuticals: Major

Jean Bizzari

Director/Board Member

TRANSGENE Biotechnology

Jean Bizzari

Director/Board Member

MADRIGAL PHARMACEUTICALS, INC. Pharmaceuticals: Major

James Daly

Director/Board Member

ARGENX SE Pharmaceuticals: Other

James Daly

Director/Board Member

Engineering & Construction

James Daly

Corporate Officer/Principal

North Park University College/University

Kurt Gustafson

Undergraduate Degree

Investment Managers

James Daly

Corporate Officer/Principal

ACADIA PHARMACEUTICALS INC. Pharmaceuticals: Major

James Daly

Director/Board Member

State University of New York at Buffalo College/University

James Daly

Masters Business Admin

CHIMERIX, INC. Pharmaceuticals: Major

James Daly

Director/Board Member

INCYTE CORPORATION Pharmaceuticals: Major

James Daly

Corporate Officer/Principal

BELLICUM PHARMACEUTICALS, INC. Biotechnology

James Daly

Director/Board Member

ONCTERNAL THERAPEUTICS, INC. Pharmaceuticals: Major

Igor Bilinsky

Corporate Officer/Principal

Statistik

International

Vereinigte Staaten 45
Frankreich 4
Niederlande 3
Schweiz 2

Sektoral

Health Technology 35
Consumer Services 8
Commercial Services 4
Finance 3
Health Services 2

Operativ

Corporate Officer/Principal 94
Director/Board Member 87
Chief Tech/Sci/R&D Officer 36
Independent Dir/Board Member 34
Undergraduate Degree 28
  1. Börse
  2. Insiders
  3. Douglas B. Muchmore
  4. Unternehmensverbindungen
-40 % Einmalige Verlängerung: Unsere Abonnements führen Sie zu den besten Investitionen von morgen
PROFITIEREN SIE JETZT